Highlights Orion S.A.

Equities

OEC

LU1092234845

Specialty Chemicals

Real-time Estimate Cboe BZX Other stock markets 13:14:08 2025-06-13 EDT			5-day change	1st Jan Change
11.16 ^USD	-1.15%		-0.53%	-28.88%

06-03	US FDA Approves New Indication for Bayer, Orion's Prostate Cancer Treatment	MT
05-29	Hyperscale Data Inc, Orion Terminate Purchase Agreement	RE

Highlights

US FDA Approves New Indication for Bayer, Orion's Prostate Cancer Treatment	06-03	MT
Orion, Shilpa Medicare Enter Commercial Deal for Albumin Product in Europe	05-23	MT
Orion S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	05-07	CI
Earnings Flash (OEC) ORION Reports Q1 Adjusted EPS $0.22, vs. FactSet Est of $0.43	05-07	MT
Earnings Flash (OEC) ORION ENGINEERED CARBONS S.A. Posts Q1 Revenue $477.7M, vs. FactSet Est of $485.6M	05-07	MT
Orion Keeps Interim Quarterly Dividend at $0.0207 a Share, Payable July 2 to Holders as of June 11	04-25	MT
Orion to License Criceto's Parkinson's Rescue Spray	04-25	MT
Orion S.A. Declares Interim Quarterly Dividend, Payable on July 2, 2025	04-24	CI
Orion Affirms FY25 Net Sales, Operating Profit Outlook	04-23	MT
Orion Plans New UK Biologics Research Center	03-10	MT
Orion to Use Aiforia's Software for Preclinical Histology	03-05	MT
Orion Maintains Quarterly Dividend at $0.0207 Per Share, Payable April 4 to Shareholders of Record on March 13	02-27	MT
Orion S.A. Declares Interim Quarterly Dividend, Payable on April 4, 2025	02-27	CI
Orion Projects FY25 Net Sales, Operating Profit Growth	02-25	MT
TMS Co., Ltd. Provided Notice on the Status of JX10 (TMS-007) Clinical Trial Application in China	02-21	CI
Tranche Update on Orion S.A.'s Equity Buyback Plan announced on May 5, 2023.	02-20	CI
Orion S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	02-19	CI
Orion Signs Tire Pyrolysis Oil Supply Deal With Contec	02-04	MT
Orion, Invenra Enter Research Partnership for Bispecific Antibody Cancer Therapeutics	01-30	MT
Orion Announces A New Collaboration with Snowflake	01-27	CI
UBS Trims Price Target on Orion to $23 From $24, Keeps Buy Rating	01-22	MT
I-80 Gold Brief: Said Overnight Completed Conditions To Amend And Restate Convertible Credit Agreement With Orion	01-16	MT
Europe's STOXX 600 at five-week high as luxury firms, chipmakers jump	01-16	RE
Orion Sees 2024 Adjusted EBITDA 'Nominally Below' Guidance; Shares Fall After Hours	01-15	MT
Orion raises forecasts for 2024	01-15	FW

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Orion S.A.

Equities

OEC

LU1092234845

Specialty Chemicals

Highlights

Filters